Monthly Archives: April 2014

Research Expands Understanding of Biomarker for Biothera Cancer Immunotherapy Imprime PGG

Research Expands Understanding of Biomarker for Biothera Cancer Immunotherapy Imprime PGG

Study to be presented at American Association for Cancer Research Meeting EAGAN, MN — April 7, 2014 — Research further elucidating the role of the biomarker for Biothera’s cancer immunotherapy Imprime PGG® will be presented today at the American Association for Cancer Research’s (AACR) annual meeting in San Diego. Previous research identified that anti-beta glucan antibodies (ABA), specifically IgG and IgM, are required for human...

Read More